Literature DB >> 25589812

(18)F-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney.

Hakan Ozturk1.   

Abstract

Mucinous tubular and spindle cell carcinoma of the kidney (MTSCC-K) is an extremely rare carcinoma of the kidney, which develops by malignant differentiation of the collecting ducts or the loop of Henle. The tumor can occur at all ages, with 4 times higher prevalence in females than in males. A 62-year-old female patient presented with an asymptomatic mass lesion in the left kidney. The ultrasound revealed a hyperechogenic mass lesion measuring 4 cm in diameter and centrally located in the left kidney. Computed tomography (CT) revealed an isodense mass lesion measuring 4 cm in diameter and posterolaterally located in the left kidney. Magnetic resonance imaging revealed a renal mass of 4 cm in diameter with hypervascular contrast uptake. For primary staging, (18)F-fluorodeoxyglucose-positron-emission tomography ((18)FDG-PET)/CT revealed left renal cell carcinoma (RCC) with a maximum standard uptake value of 6.7. The patient underwent transperitoneal radical nephrectomy. The immunohistochemical examination revealed MTSCC-K. (18)FDG-PET/CT provides 81-89% sensitivity and 83-100% specificity in primary staging of the renal cancers, in diagnosing metastatic RCC, and monitoring the response to therapy. Its use in the staging of MTSCC of the kidney has not been previously described in the literature. This case highlights the usefulness of (18)FDG-PET/CT in the staging of this rare tumor.

Entities:  

Keywords:  Mucinous tubular and spindle cell carcinoma of the kidney; positron-emission tomography/computed tomography; renal cancer; staging

Year:  2015        PMID: 25589812      PMCID: PMC4290072          DOI: 10.4103/0972-3919.147550

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


  8 in total

1.  Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.

Authors:  S Ramdave; G W Thomas; S U Berlangieri; D M Bolton; I Davis; H T Danguy; D Macgregor; A M Scott
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

2.  18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.

Authors:  Xiang-Hua Ye; Long-Hua Chen; Hu-Bing Wu; Jie Feng; Wen-Lan Zhou; Rui-Meng Yang; Zhi-Bin Bu; Yi Ding; Jian Guan; Quan-Shi Wang
Journal:  South Med J       Date:  2010-07       Impact factor: 0.954

3.  Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.

Authors:  Hideshi Miyakita; Masatosi Tokunaga; Hajime Onda; Yukio Usui; Hidechika Kinoshita; Nobuo Kawamura; Seiei Yasuda
Journal:  Int J Urol       Date:  2002-01       Impact factor: 3.369

4.  Role of FDG PET-CT in recurrent renal cell carcinoma.

Authors:  Rakesh Kumar; Varun Shandal; Shamim Ahmed Shamim; Sunil Jeph; Harmandeep Singh; Arun Malhotra
Journal:  Nucl Med Commun       Date:  2010-10       Impact factor: 1.690

5.  Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma.

Authors:  Francesco Bertagna; Federica Motta; Mattia Bertoli; Giovanni Bosio; Simona Fisogni; Regina Tardanico; Vittorio Ferrari; Alessandro Antonelli; Claudio Simeone; Sergio Cosciani Cunico; Raffaele Giubbini
Journal:  Nucl Med Rev Cent East Eur       Date:  2013

6.  Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change.

Authors:  Jasreman Dhillon; Mahul B Amin; Elena Selbs; George K Turi; Gladell P Paner; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

7.  Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.

Authors:  Paolo Cossu-Rocca; John N Eble; Brett Delahunt; Shaobo Zhang; Guido Martignoni; Matteo Brunelli; Liang Cheng
Journal:  Mod Pathol       Date:  2006-04       Impact factor: 7.842

Review 8.  Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.

Authors:  Hsin-Yi Wang; Hueisch-Jy Ding; Jin-Hua Chen; Chih-Hao Chao; Yu-Yu Lu; Wan-Yu Lin; Chia-Hung Kao
Journal:  Cancer Imaging       Date:  2012-10-26       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.